Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FALCK HEALTHCARE A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   10.8% 30.0% 49.7% 49.0% 1.5% 0.7% 4.0% 3.7%   Credit score (0-100)   24 2 0 0 75 93 49 52   Credit rating   BB C C C A AA BBB BBB   Credit limit (mDKK)   -0.0 0.0 0.0 0.0 0.6 46.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   656 0 0 0 328 310 310 310   Gross profit   93.6 293 134 148 181 163 0.0 0.0   EBITDA   -21.1 293 134 148 -16.0 -0.7 0.0 0.0   EBIT   -136 293 134 148 -46.4 -27.1 0.0 0.0   Pre-tax profit (PTP)   -136.2 15.8 -78.4 -76.6 -82.9 -26.0 0.0 0.0   Net earnings   -104.4 15.8 -78.4 -76.6 -71.4 -12.2 0.0 0.0   Pre-tax profit without non-rec. items   -136 293 134 148 -82.9 -26.0 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2.3 0.0 0.0 0.0 0.4 0.4 0.0 0.0   Shareholders equity total   17.7 0.0 0.0 0.0 160 498 495 495   Interest-bearing liabilities   142 0.0 0.0 0.0 1,359 1,041 0.0 0.0   Balance sheet total (assets)   509 0.0 0.0 0.0 1,583 1,592 495 495   Net Debt   140 0.0 0.0 0.0 1,359 1,041 -475 -475     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   656 0 0 0 328 310 310 310   Net sales growth   -4.5% -100.0% 0.0% 0.0% 0.0% -5.5% 0.0% 0.0%   Gross profit   93.6 293 134 148 181 163 0.0 0.0   Gross profit growth   -32.1% 212.6% -54.0% 10.2% 21.9% -9.9% -100.0% 0.0%   Employees   586 0 0 0 332 281 0 0   Employee growth %   54.2% -100.0% 0.0% 0.0% 0.0% -15.4% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   509 0 0 0 1,583 1,592 495 495   Balance sheet change%   -3.9% -100.0% 0.0% 0.0% 0.0% 0.6% -68.9% 0.0%   Added value   -21.1 292.6 134.5 148.2 -46.4 -0.7 0.0 0.0   Added value %   -3.2% 0.0% 0.0% 0.0% -14.2% -0.2% 0.0% 0.0%   Investments   -218 -63 0 0 18 -53 -1 0   Net sales trend   -1.0 -2.0 0.0 0.0 0.0 -1.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 3.0 -1.0 -2.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   -3.2% 0.0% 0.0% 0.0% -4.9% -0.2% 0.0% 0.0%   EBIT %   -20.7% 0.0% 0.0% 0.0% -14.2% -8.8% 0.0% 0.0%   EBIT to gross profit (%)   -145.1% 100.0% 100.0% 100.0% -25.7% -16.7% 0.0% 0.0%   Net Earnings %   -15.9% 0.0% 0.0% 0.0% -21.8% -3.9% 0.0% 0.0%   Profit before depreciation and extraordinary items %   1.6% 0.0% 0.0% 0.0% -12.5% 4.6% 0.0% 0.0%   Pre tax profit less extraordinaries %   -20.8% 0.0% 0.0% 0.0% -25.3% -8.4% 0.0% 0.0%   ROA %   -26.2% 115.0% 0.0% 0.0% -2.9% 1.3% 0.0% 0.0%   ROI %   -61.8% 367.3% 0.0% 0.0% -3.0% 1.4% 0.0% 0.0%   ROE %   -198.9% 178.7% 0.0% 0.0% -44.6% -3.7% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   5.4% 0.0% 0.0% 0.0% 10.2% 31.5% 100.0% 100.0%   Relative indebtedness %   74.9% 0.0% 0.0% 0.0% 434.0% 353.3% 0.0% 0.0%   Relative net indebtedness %   74.7% 0.0% 0.0% 0.0% 434.0% 353.3% -153.3% -153.3%   Net int. bear. debt to EBITDA, %   -664.4% 0.0% 0.0% 0.0% -8,476.0% -143,141.1% 0.0% 0.0%   Gearing %   799.0% 0.0% 0.0% 0.0% 848.9% 209.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.4% 0.0% 0.0% 0.0% 5.4% 3.9% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.4 0.0 0.0 0.0 0.5 0.5 0.0 0.0   Current Ratio   0.9 0.0 0.0 0.0 0.5 0.5 0.0 0.0   Cash and cash equivalent   1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   109.2 0.0 0.0 0.0 42.1 44.8 0.0 0.0   Trade creditors turnover (days)   99.0 0.0 0.0 0.0 11.2 39.1 0.0 0.0   Current assets / Net sales %   67.7% 0.0% 0.0% 0.0% 31.7% 31.1% 153.3% 153.3%   Net working capital   -47.4 0.0 0.0 0.0 -123.3 -102.7 0.0 0.0   Net working capital %   -7.2% 0.0% 0.0% 0.0% -37.6% -33.2% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   1 0 0 0 1 1 0 0   Added value / employee   -0 0 0 0 -0 -0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -0 0 0 0 -0 -0 0 0   EBIT / employee   -0 0 0 0 -0 -0 0 0   Net earnings / employee   -0 0 0 0 -0 -0 0 0